BIA 2-093 CAS 236395-14-5 with Molecular Weight 296.32100

Product Description:

Product Name: BIA 2-093 CAS NO: 236395-14-5

Synonyms:

EslicarbazepineAcetate;

S-(−)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide;

[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate;

Chemical & Physical Properties:

Appearance: White to Off-White Solid

Assay :≥99.0%

Density: 1.32g/cm3

Boiling Point: 427.4℃ at 760mmHg

Melting Point: 183-185℃

Flash Point: 212.3℃

Refractive Index: 1.655

Storage Condition: 2-8℃

Vapor Pressure: 1.65E-07mmHg at 25℃

Safety Information:

Safety Statements: S26; S36

Risk Statements: R36/37/38

Hazard Code: Xi

Caution Statement: P261; P305 + P351 + P338

Symbol: GHS07

Hazard Declaration: H315; H319; H335

Signal Word: Warning

Eslicarbazepine acetate (trade names Aptiom in the US and Zebinix in Europe), abbreviated as ESL, is an anticonvulsant medication approved for use in Europe and the United States as monotherapy or adjunctive therapy (additional therapy) for partial-onset seizures epilepsy.

Similarly to oxcarbazepine, ESL behaves as a prodrug to (es)licarbazepine. As such, their mechanisms of action are identical.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.